Post-Traumatic Stress Disorder (PTSD) Treatment Market

Future Market Insights

Key Insight

The post-traumatic stress disorder (ptsd) treatment market is projected to grow from USD 18.5 billion in 2025 to USD 30.2 billion by 2035, at a CAGR of 5.0%. Antidepressants will dominate with a 48.6% market share, while retail pharmacies will lead the distribution channel segment with a 56.3% share.

September 10, 2025

Anurag Sharma

290 Pages

Cite this Report

Post-Traumatic Stress Disorder (PTSD) Treatment Market

https://www.futuremarketinsights.com/reports/post-traumatic-stress-disorder-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Aurobindo Pharma
Bionomics Limited
GSK
The Vanguard Group
Viatris Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Post-Traumatic Stress Disorder (PTSD) Treatment Market

Key Players

Similar Industry Reports